Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Grace Bugos

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Cancer Cell|April 12, 2022
Synthetic HLA-independent T cell receptors for cancer immunotherapySylvain Simon, Grace Bugos, Stanley R Riddell
Current Opinion in Immunology|September 27, 2021
Synthetic receptors for logic gated T cell recognition and functionSylvain Simon, Grace Bugos, Alex I Salter, et al.
Methods in Molecular Biology (Clifton, N.J.)|August 1, 2019
Genomics-Driven Immunoproteomics: An Integrative Platform to Uncover Important Biomarkers for Human DiseasesRaghavendra Giri, Veneta Qendro, Pooja Rani, et al.
STAR Protocols|October 1, 2020
AbSeq Protocol Using the Nano-Well Cartridge-Based Rhapsody Platform to Generate Protein and Transcript Expression Data on the Single-Cell LevelJami R Erickson, Florian Mair, Grace Bugos, et al.
Proteomics|July 1, 2017
Discovery of putative breast cancer antigens using an integrative platform of genomics-driven immunoproteomicsVeneta Qendro, Deborah H Lundgren, Samuel Palczewski, et al.
The Journal of Biological Chemistry|September 12, 2020
Expression of a TMC6-TMC8-CIB1 heterotrimeric complex in lymphocytes is regulated by each of the componentsChuan-Jin Wu, Xing Li, Connie L Sommers, et al.
Research Square|May 15, 2024
Sensitive bispecific chimeric T cell receptors for cancer therapySylvain Simon, Grace Bugos, Rachel Prins, et al.
Nature Cancer|March 18, 2025
Design of sensitive monospecific and bispecific synthetic chimeric T cell receptors for cancer therapySylvain Simon, Grace Bugos, Rachel Prins, et al.
Immunity|February 14, 2024
Signaling via a CD27-TRAF2-SHP-1 axis during naive T cell activation promotes memory-associated gene regulatory networksCarla A Jaeger-Ruckstuhl, Yun Lo, Elena Fulton, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Cancer Cell|April 12, 2022
Synthetic HLA-independent T cell receptors for cancer immunotherapySylvain Simon, Grace Bugos, Stanley R Riddell
Current Opinion in Immunology|September 27, 2021
Synthetic receptors for logic gated T cell recognition and functionSylvain Simon, Grace Bugos, Alex I Salter, et al.
Methods in Molecular Biology (Clifton, N.J.)|August 1, 2019
Genomics-Driven Immunoproteomics: An Integrative Platform to Uncover Important Biomarkers for Human DiseasesRaghavendra Giri, Veneta Qendro, Pooja Rani, et al.
STAR Protocols|October 1, 2020
AbSeq Protocol Using the Nano-Well Cartridge-Based Rhapsody Platform to Generate Protein and Transcript Expression Data on the Single-Cell LevelJami R Erickson, Florian Mair, Grace Bugos, et al.
Proteomics|July 1, 2017
Discovery of putative breast cancer antigens using an integrative platform of genomics-driven immunoproteomicsVeneta Qendro, Deborah H Lundgren, Samuel Palczewski, et al.
The Journal of Biological Chemistry|September 12, 2020
Expression of a TMC6-TMC8-CIB1 heterotrimeric complex in lymphocytes is regulated by each of the componentsChuan-Jin Wu, Xing Li, Connie L Sommers, et al.
Research Square|May 15, 2024
Sensitive bispecific chimeric T cell receptors for cancer therapySylvain Simon, Grace Bugos, Rachel Prins, et al.
Nature Cancer|March 18, 2025
Design of sensitive monospecific and bispecific synthetic chimeric T cell receptors for cancer therapySylvain Simon, Grace Bugos, Rachel Prins, et al.
Immunity|February 14, 2024
Signaling via a CD27-TRAF2-SHP-1 axis during naive T cell activation promotes memory-associated gene regulatory networksCarla A Jaeger-Ruckstuhl, Yun Lo, Elena Fulton, et al.
Pageof 1